Showing results (81-90 of 244) with videos related to

Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2021
Acute GVHD Diagnosis and Adjudication in a Multicenter Trial: A Report From the BMT CTN 1202 Biorepository StudyRan Reshef, Wael Saber, Javier Bolaños-Meade, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 21, 2011
Expression of activating KIR2DS2 and KIR2DS4 genes after hematopoietic cell transplantation: relevance to cytomegalovirus infectionGhislaine M Gallez-Hawkins, Anne E Franck, Xiuli Li, et al.
Blood|September 9, 2022
Trafficking between clonally related peripheral T-helper cells and tissue-resident T-helper cells in chronic GVHDXiaohui Kong, Xiwei Wu, Bixin Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 2, 2015
Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell TransplantationSamer K Khaled, Joycelynne M Palmer, Josef Herzog, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 2, 2011
A phase I study in adults of clofarabine combined with high-dose melphalan as reduced-intensity conditioning for allogeneic transplantationMark H Kirschbaum, Anthony S Stein, Leslie Popplewell, et al.
Transplantation and Cellular Therapy|December 27, 2022
Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 StudySantosh Putta, Bradford A Young, John E Levine, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 19, 2018
Outcomes of Patients with Recurrent and Refractory Lymphoma Undergoing Allogeneic Hematopoietic Cell Transplantation with BEAM Conditioning and Sirolimus- and Tacrolimus-Based GVHD ProphylaxisAmandeep Salhotra, Matthew Mei, Tracey Stiller, et al.
International Journal of Molecular Sciences|September 28, 2024
Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central StudyFei Fei, Amar Jariwala, Sheeja Pullarkat, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 17, 2019
Cost analysis of ganciclovir and foscarnet in recipients of allogeneic hematopoietic cell transplant with cytomegalovirus viremiaJason Chen, Justine Abella Ross, Bernard Tegtmeier, et al.
BMC Cancer|August 5, 2020
Technology-enabled activation of skin cancer screening for hematopoietic cell transplantation survivors and their primary care providers (TEACH)Saro H Armenian, Lanie Lindenfeld, Aleksi Iukuridze, et al.
Pageof 25